SYNERGY¿
Report
- Report Number
- 2134265-2018-05126
- Event Type
- Malfunction
- Date Received
- June 11, 2018
- Report Date
- May 15, 2018
- Manufacturer
- BOSTON SCIENTIFIC - GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- SIMILAR
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
FUJIMOTO, YOSHIHIE, ET. AL., 'DELAMINATION OF NOVEL ULTRATHIN BIOABSORBABLE ABLUMINAL POLYMER OF PLATINUM CHROMIUM EVEROLIMUS-ELUTING STENT', CARDIOASC INTERV AND THER 2018 33:97-98, HTTPS://DOI.ORG/10.1007/S12928-016-0442-9. DEVICE IS A COMBINATION PRODUCT. (B)(6). (B)(4). DEVICE EVALUATED BY MFR: THE COMPLAINT DEVICE WAS NOT RECEIVED FOR ANALYSIS. THE INVESTIGATION CONCLUSION IS OPERATIONAL CONTEXT AS THE PRODUCT MEETS THE DESIGN & MANUFACTURE SPECIFICATION BUT DUE TO ANATOMICAL/PROCEDURAL FACTORS ENCOUNTERED DURING THE PROCEDURE, PERFORMANCE WAS LIMITED. (B)(4).
IT WAS REPORTED VIA LITERATURE THAT POLYMER DELAMINATION OCCURRED. THE 90% STENOSED TARGET LESION WAS LOCATED IN THE SEVERELY CALCIFIED MID-LEFT ANTERIOR DESCENDING CORONARY ARTERY (LAD). AFTER PREDILATATION, DELIVERY OF A 24MM SYNERGY STENT IN THE MID-LAD WAS ATTEMPTED. HOWEVER, IT WOULD NOT ADVANCE TO THE TARGET LESION IN THE MID-LAD EVEN WITH THE A NON-BSC GUIDE EXTENSION CATHETER. ROTATIONAL ATHERECTOMY WAS PERFORMED. A DURABLE POLYMER EVEROLIMUS-ELUTING STENT WAS THEN DEPLOYED. THE FINAL ANGIOGRAM SHOWED A GOOD RESULT. SCANNING ELECTRON MICROSCOPY DEMONSTRATED DAMAGE TO THE BIOABSORBABLE POLYMER OF THE SYNERGY STENT; MOST OF THE DAMAGE WAS DELAMINATION OF ABLUMINAL POLYMER. IT WAS CONCLUDED THAT DELAMINATION OF ABLUMINAL BIOABSORBABLE POLYMER MAY OCCUR MORE EASILY AND SEVERELY WHEN IT IS DELIVERED THROUGH A CALCIFIED CORONARY ARTERY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 430024 | SYNERGY¿ | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - GALWAY | UNK776 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 76 YR |